Nine of our senior team made the trip to Copenhagen to represent Mtech Access at ISPOR Europe this November. The conference brought together leading experts from across Health Economics and Outcomes Research to share ideas and explore the latest trends. At our booth, we were delighted to meet with a number of current and past clients. We also had some interesting conversations with some great new contacts.
A big highlight for us was the poster presentations. We entered five posters under the Mtech Access brand and were thrilled when we received a top 10% rosette for one of our systematic review posters.
Scroll down to find out more about each of our five posters and what inspired us to present these topics at ISPOR.
Poster 1: Delay in diagnosis of primary lymphoedema and its impact on quality of life: a systematic review
Mtech Access Consultant, Catherine Mitchell, conducted this research in collaboration with her friend Dr Catherine O’Leary (a portfolio GP), whose daughter and husband both have primary lymphoedema.
Lymphoedema is a chronic condition that, if left untreated, can severely impact on patients’ quality of life. With no standardised education on primary lymphoedema offered to healthcare professionals in England, the condition is often under or misdiagnosed. Early diagnosis and treatment reduces its psychological and social impact and prevents disease progression and complications.
The objectives and conclusions of this research examining the time from initial symptoms to diagnosis are summarised here on the ISPOR presentation database.
Prior to ISPOR, Dr Catherine O’Leary was invited to present the preliminary results of the research at the British Lymphology Society, where she won “best overall oral presentation”.
Posters 2 and 3: Systematic reviews on the long-term effects of a therapy on chronic kidney disease and heart failure
These two posters present systematic reviews conducted in collaboration with one of clients, who chose Mtech Access to support their evidence generation.
Our team were thrilled when one of these poster received a top 10% rosette.
Sarah Batson, who leads our statistical analysis capability, is pictured with the poster in the exhibit hall at ISPOR Europe.
Contact Sarah at firstname.lastname@example.org if you would like to find out more about this research or to request a copy of our poster.
Poster 4: Updated meta-analysis of the efficacy of an adjuvant treatment in Parkinson’s disease
You can learn more about our approach and findings in the ISPOR presentation database.
This meta-analysis was originally conducted to support a client’s evidence submission as part of their broader market access strategy.
Contact Stephen Mitchell on email@example.com if you would like to find out more about this research or to request a copy of our poster.
Poster 5: Animal assisted therapy (AAT) in depression and anxiety: a systematic review
We also submitted a systematic review into how Animal Assisted Therapy (AAT) can support patients with depression and anxiety.
Interestingly, a wide range of animals were employed as part of the AAT regimen including dogs, cats, and horses, as well as dolphins and farm animals such as cows, pigs, and chickens.
Click here to access a summary of the research on the ISPOR database.
ISPOR Europe saw us present five posters under the Mtech Access brand. In addition, one of our clients also presented a poster featuring research conducted by our evidence team as part of a recent project.
Our posters featured independent research on topics close to our team members’ hearts, along with presentations of evidence commissioned by our clients to further their market access strategies.
We continue to prepare presentations for upcoming events and would be delighted to hear from anyone interested in submitting a poster or working with our evidence team.
If you work in market access in Pharma, Bio-Pharma, or Medical Devices and would like to discuss how our evidence team can support your market access strategy by submitting evidence at conferences like ISPOR, contact Stephen Mitchell on firstname.lastname@example.org.